APA (7th ed.) Citation

RL, H., RL, G., S, M., GH, D., CL, F., CW, F., . . . S, S. (2018). Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure. Diabetes care, 41(4), 823. https://doi.org/10.2337/dc17-1387

Chicago Style (17th ed.) Citation

RL, Hull, Gibson RL, McNamara S, Deutsch GH, Fligner CL, Frevert CW, Ramsey BW, and Sanda S. "Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure." Diabetes Care 41, no. 4 (2018): 823. https://doi.org/10.2337/dc17-1387.

MLA (9th ed.) Citation

RL, Hull, et al. "Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure." Diabetes Care, vol. 41, no. 4, 2018, p. 823, https://doi.org/10.2337/dc17-1387.